A clinical trial of TCR-modified T cells.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2017
At a glance
- Drugs TCR-transduced lymphocytes (Primary)
- Indications Autoimmune disorders; T-cell leukaemia
- Focus Adverse reactions
- 27 Mar 2017 New trial record
- 23 Mar 2017 According to a Medigene AG media release, complany plans to initiate this trial in second half of 2018.